SATSUMA PHARMACEUTICALS, INC. (STSA): Price and Financial Metrics

SATSUMA PHARMACEUTICALS, INC. (STSA): $1.10

0.01 (-0.90%)

POWR Rating

Component Grades

Momentum

B

Stability

D

Sentiment

Quality

C

Add STSA to Watchlist
Sign Up

Industry: Biotech

Industry

NR

Ranked

#140 of 382

in industry

STSA Price/Volume Stats

Current price $1.10 52-week high $8.08
Prev. close $1.11 52-week low $0.59
Day low $1.01 Volume 1,829,700
Day high $1.14 Avg. volume 701,788
50-day MA $0.97 Dividend yield N/A
200-day MA $2.38 Market Cap 36.47M

STSA Stock Price Chart Interactive Chart >


SATSUMA PHARMACEUTICALS, INC. (STSA) Company Bio


Satsuma Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. It develops novel therapeutic products for the acute treatment of migraine. The company was founded by John Kollins on June 21, 2016 and is headquartered in San Francisco, CA.


STSA Latest News Stream


Event/Time News Detail
Loading, please wait...

STSA Latest Social Stream


Loading social stream, please wait...

View Full STSA Social Stream

STSA Price Returns

1-mo N/A
3-mo N/A
6-mo N/A
1-year N/A
3-year -80.14%
5-year -92.86%
YTD N/A
2023 0.00%
2022 -80.00%
2021 -2.39%
2020 -76.58%
2019 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!